Tuesday, 9 July 2013

New trial alert: High dose-rate brachytherapy in low and intermediate risk prostate cancer

The Sunnybrook Health Sciences Centre is presently recruiting patients for a clinical trial aimed at determining the effects of a single high dose rate brachytherapy (HDR) treatment together with a short course of external beam radiation therapy (EBRT) for men with low and intermediate risk prostate cancer.  The primary outcome of this study is to investigate patient reported toxicity and health-related quality of life after a one-year period. 

To read more about this randomized phase II trial, click here

No comments:

Post a Comment